Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct;33(5):507-11.
doi: 10.1007/s10545-010-9080-z. Epub 2010 Apr 29.

Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency

Affiliations
Review

Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency

Bianca T van Maldegem et al. J Inherit Metab Dis. 2010 Oct.

Abstract

Short-chain acyl-CoA dehydrogenase deficiency (SCADD) is an autosomal recessive inborn error of mitochondrial fatty acid oxidation. SCADD is biochemically characterized by increased C4-carnitine in plasma and ethylmalonic acid in urine. The diagnosis of SCADD is confirmed by DNA analysis showing SCAD gene mutations and/or variants. SCAD gene variants are present in homozygous form in approximately 6% of the general population and considered to confer susceptibility to development of clinical disease. Clinically, SCADD generally appears to present early in life and to be most frequently associated with developmental delay, hypotonia, epilepsy, behavioral disorders, and hypoglycemia. However, these symptoms often ameliorate and even disappear spontaneously during follow-up and were found to be unrelated to the SCAD genotype. In addition, in some cases, symptoms initially attributed to SCADD could later be explained by other causes. Finally, SCADD relatives of SCADD patients as well as almost all SCADD individuals diagnosed by neonatal screening remained asymptomatic during follow-up. This potential lack of clinical consequences of SCADD has several implications. First, the diagnosis of SCADD should never preclude extension of the diagnostic workup for other potential causes of the observed symptoms. Second, patients and parents should be clearly informed about the potential lack of relevance of the disorder to avoid unfounded anxiety. Furthermore, to date, SCADD is not an optimal candidate for inclusion in newborn screening programs. More studies are needed to fully establish the relevance of SCADD and solve the question as to whether SCADD is involved in a multifactorial disease or represents a nondisease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Comparison of the number of symptoms in metabolically screened patients to the number of symptoms at presentation in the Dutch short-chain acyl-CoA dehydrogenase deficiency (SCADD) patients group

Similar articles

Cited by

References

    1. Amendt BA, Greene C, Sweetman L, Cloherty J, Shih V, Moon A, Teel L, Rhead WJ. Short-chain acyl-coenzyme a dehydrogenase deficiency. Clinical and biochemical studies in two patients. J Clin Invest. 1987;79:1303–1309. doi: 10.1172/JCI112953. - DOI - PMC - PubMed
    1. Baerlocher KE, Steinmann B, Aguzzi A, Krahenbuhl S, Roe CR, Vianey-Saban C. Short-chain acyl-CoA dehydrogenase deficiency in a 16-year-old girl with severe muscle wasting and scoliosis. J Inherit Metab Dis. 1997;20:427–431. doi: 10.1023/A:1005319120751. - DOI - PubMed
    1. Bhala A, Willi SM, Rinaldo P, Bennett MJ, Schmidt-Sommerfeld E, Hale DE. Clinical and biochemical characterization of short-chain acyl-coenzyme a dehydrogenase deficiency. J Pediatr. 1995;126:910–915. doi: 10.1016/S0022-3476(95)70207-5. - DOI - PubMed
    1. Birkebaek NH, Simonsen H, Gregersen N. Hypoglycaemia and elevated urine ethylmalonic acid in a child homozygous for the short-chain acyl-CoA dehydrogenase 625G>A gene variation. Acta Paediatr. 2002;91:480–482. doi: 10.1080/080352502317371751. - DOI - PubMed
    1. Bok LA, Vreken P, Wijburg FA, Wanders RJ, Gregersen N, Corydon MJ, Waterham HR, Duran M. Short-chain Acyl-CoA dehydrogenase deficiency: studies in a large family adding to the complexity of the disorder. Pediatrics. 2003;112:1152–1155. doi: 10.1542/peds.112.5.1152. - DOI - PubMed

MeSH terms

Supplementary concepts